Loading...
Good response with durvalumab after chemoradiotherapy for epidermal growth factor receptor exon 20 insertion adenocarcinoma: A case report
Epidermal growth factor receptor (EGFR) exon 20 insertion is not associated with sensitivity to EGFR tyrosine kinase inhibitors and chemotherapy. Here, we report the case of a 41-year-old man who presented a right lower lobe nodule and mediastinal lymph node enlargement diagnosed as EGFR exon 20 ins...
Na minha lista:
| Udgivet i: | Respir Med Case Rep |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7552097/ https://ncbi.nlm.nih.gov/pubmed/33083220 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101236 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|